Cholelithiasis News and Research

RSS
Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Estrogen therapy may increase risk for gallbladder disease

Estrogen therapy may increase risk for gallbladder disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.